Subscribe to PRO at just Rs.33 per month. Use code SUPERPRO
Last Updated : Jul 16, 2020 05:08 PM IST | Source: PTI

P-notes investment climbs to Rs 62,138 crore until June

According to Sebi data, the value of P-note investments in Indian markets -- equity, debt, hybrid securities and derivatives -- stood at Rs 62,138 crore until June, while the same was at Rs 60,027 crore at the end of May.


Investments through participatory notes (P-notes) in the domestic capital market surged to Rs 62,138 crore till June-end, making it the third consecutive monthly rise. P-notes are issued by registered foreign portfolio investors (FPIs) to overseas investors, who wish to be part of the Indian stock market without registering themselves directly. They, however, need to go through a due diligence process.

According to Sebi data, the value of P-note investments in Indian markets -- equity, debt, hybrid securities and derivatives -- stood at Rs 62,138 crore until June, while the same was at Rs 60,027 crore at the end of May.

Prior to that, investment level was at Rs 57,100 crore at the end of April.


The investment level had fallen to an over 15-year-low of Rs 48,006 crore at the end of March.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more

The figure at March-end was the lowest level of investment since October 2004, when the total value of P-note investments in the Indian markets stood at Rs 44,586 crore.

The lower figure in March came amid significant volatility in broader markets on concerns over coronavirus-triggered crisis.

Of the total Rs 62,138 crore invested through the route till June, Rs 52,171 crore was invested in equities, Rs 9,572 crore in debt, Rs 231 crore in the hybrid securities and Rs 164 crore in derivatives segment.

Fund inflow through the route stood at Rs 68,862 crore, Rs 67,281 crore and 64,537 crore at the end of February 2020, January 2020 and December 2019, respectively. However, it was at Rs 69,670 crore at November-end last year.

Market experts said that P-note is now not a preferred route for investing in India after Sebi made registration process easier for FPIs. However, due to certain taxation laws in India, FPIs still want to explore this route.

Earlier in September, Securities and Exchange Board of India (Sebi) simplified know-your-customer (KYC) requirements and registration process for FPIs. Besides, the regulator broad-based the classification of such investors.

Meanwhile, FPIs pumped in a net sum of Rs 26,000 crore in the capital markets (equity and debt) in June after pulling out Rs 7,355 crore in May.
First Published on Jul 16, 2020 05:08 pm